Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group-Reference-Cited by-同舟云学术

Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group

Published:2010-08 Issue:4 Volume:10 Page:290-296
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Johnsen Hans E.,Klausen Tobias W.,Boegsted Martin,Lenhoff Stig,Gimsing Peter,Christiansen Ilse,Gedde-Dahl Tobias,Lindås Roald,Mellqvist Ulf-Henrik

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference42 articles.

1. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials;Gregory;J Clin Oncol,1992

2. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials;J Clin Oncol,1998

3. Survival in conventionally treated younger (< 60 years) multiple myeloma patients: no improvement during 2 decades. Nordic Myeloma Study Group (NMSG);Hjorth;Eur J Haematol,1999

4. High-dose intravenous melphalan for plasma-cell leukemia and myeloma;McElwain;Lancet,1983

5. Bone marrow transplantation in multiple myeloma;Barlogie;Bone Marrow Transplant,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first-line induction therapy for newly diagnosed multiple myeloma in a single institution of China;Asia-Pacific Journal of Clinical Oncology;2016-10-14

2. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies;Cochrane Database of Systematic Reviews;2012-10-17

3. Clinical effects of autologous stem cell transplantation as consolidation treatment in 70 multiple myeloma patients: a case-controlled study;CHINESE MED J-PEKING;2011